Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Clinical trial NCT00056446 · COMPLETED

Trial details

NCT number: NCT00056446
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Neoplasms Colonic Neoplasms Rectal Neoplasms

Start date: 2003-01-01
Primary completion: 2007-01-01
Enrollment: 855

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.